82.00
+2.49(+3.13%)
Currency In USD
Address
210 Main Street West
Baudette, MN 56623
United States of America
Phone
218 634 3500
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
897
First IPO Date
May 05, 2000
| Name | Title | Pay | Year Born |
| Nikhil Lalwani | President, Chief Executive Officer & Director | 2.44M | 1978 |
| Meredith W. Cook | Senior Vice President, General Counsel & Corporate Secretary | 845,500 | 1974 |
| Chad Gassert | Senior Vice President of Corporate Development & Strategy | 849,711 | 1976 |
| Christopher K. Mutz | Senior VP & Head of Rare Disease | 919,663 | 1971 |
| Ori Gutwerg | Senior Vice President of Generics | 930,962 | 1974 |
| Stephen Carey | Senior VP of Finance & CFO | 1.14M | 1971 |
| Mary Pao | Chief Medical Officer | 0 | N/A |
| Muthusamy Shanmugam | Head of R&D, Chief Operating Officer of New Jersey Operations & Director | 0 | 1968 |
| Elizabeth Powell | Chief Compliance Officer & Head of Legal of Rare Disease | 0 | N/A |
| Krista L. Davis | Senior VP & Chief Human Resources Officer | 0 | 1973 |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.